Literature DB >> 16397500

Potentiation of neuroblastoma metastasis by loss of caspase-8.

Dwayne G Stupack1, Tal Teitz, Matthew D Potter, David Mikolon, Peter J Houghton, Vincent J Kidd, Jill M Lahti, David A Cheresh.   

Abstract

Neuroblastoma, the most common paediatric solid tumour, arises from defective neural crest cells. Genetic alterations occur frequently in the most aggressive neuroblastomas. In particular, deletion or suppression of the proapoptotic enzyme caspase-8 is common in malignant, disseminated disease, although the effect of this loss on disease progression is unclear. Here we show that suppression of caspase-8 expression occurs during the establishment of neuroblastoma metastases in vivo, and that reconstitution of caspase-8 expression in deficient neuroblastoma cells suppressed their metastases. Caspase-8 status was not a predictor of primary tumour growth; rather, caspase-8 selectively potentiated apoptosis in neuroblastoma cells invading the collagenous stroma at the tumour margin. Apoptosis was initiated by unligated integrins by means of a process known as integrin-mediated death. Loss of caspase-8 or integrin rendered these cells refractory to integrin-mediated death, allowed cellular survival in the stromal microenvironment, and promoted metastases. These findings define caspase-8 as a metastasis suppressor gene that, together with integrins, regulates the survival and invasive capacity of neuroblastoma cells.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16397500     DOI: 10.1038/nature04323

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  100 in total

1.  Carnosic acid, a rosemary phenolic compound, induces apoptosis through reactive oxygen species-mediated p38 activation in human neuroblastoma IMR-32 cells.

Authors:  Chia-Wen Tsai; Chia-Yuan Lin; Hui-Hsuan Lin; Jing-Hsien Chen
Journal:  Neurochem Res       Date:  2011-08-11       Impact factor: 3.996

Review 2.  Metastasis suppressor proteins: discovery, molecular mechanisms, and clinical application.

Authors:  Carrie W Rinker-Schaeffer; James P O'Keefe; Danny R Welch; Dan Theodorescu
Journal:  Clin Cancer Res       Date:  2006-07-01       Impact factor: 12.531

3.  Blocking SHH/Patched Interaction Triggers Tumor Growth Inhibition through Patched-Induced Apoptosis.

Authors:  Patrick Mehlen; Joanna Fombonne; Pierre-Antoine Bissey; Pauline Mathot; Catherine Guix; Mélissa Jasmin; Isabelle Goddard; Clélia Costechareyre; Nicolas Gadot; Jean-Guy Delcros; Sachitanand M Mali; Rudi Fasan; André-Patrick Arrigo; Robert Dante; Gabriel Ichim
Journal:  Cancer Res       Date:  2020-02-14       Impact factor: 12.701

4.  Caspase-8 mutations in head and neck cancer confer resistance to death receptor-mediated apoptosis and enhance migration, invasion, and tumor growth.

Authors:  Changyou Li; Ann Marie Egloff; Malabika Sen; Jennifer R Grandis; Daniel E Johnson
Journal:  Mol Oncol       Date:  2014-04-18       Impact factor: 6.603

5.  Smad7 protein induces interferon regulatory factor 1-dependent transcriptional activation of caspase 8 to restore tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated apoptosis.

Authors:  Suntaek Hong; Hye-Youn Kim; Jooyoung Kim; Huyen Trang Ha; Young-Mi Kim; Eunjin Bae; Tae Hyung Kim; Kang Choon Lee; Seong-Jin Kim
Journal:  J Biol Chem       Date:  2012-12-19       Impact factor: 5.157

6.  Microenvironmental Influences on Metastasis Suppressor Expression and Function during a Metastatic Cell's Journey.

Authors:  Wen Liu; Carolyn J Vivian; Amanda E Brinker; Kelsey R Hampton; Evi Lianidou; Danny R Welch
Journal:  Cancer Microenviron       Date:  2014-06-18

7.  Caveolin-1 promotes resistance to chemotherapy-induced apoptosis in Ewing's sarcoma cells by modulating PKCalpha phosphorylation.

Authors:  Oscar M Tirado; Caitlin M MacCarthy; Naheed Fatima; Joaquín Villar; Silvia Mateo-Lozano; Vicente Notario
Journal:  Int J Cancer       Date:  2010-01-15       Impact factor: 7.396

8.  Distinct FAK-Src activation events promote alpha5beta1 and alpha4beta1 integrin-stimulated neuroblastoma cell motility.

Authors:  L Wu; J A Bernard-Trifilo; Y Lim; S-T Lim; S K Mitra; S Uryu; M Chen; C J Pallen; N-Kv Cheung; D Mikolon; A Mielgo; D G Stupack; D D Schlaepfer
Journal:  Oncogene       Date:  2007-09-10       Impact factor: 9.867

9.  Th-MYCN mice with caspase-8 deficiency develop advanced neuroblastoma with bone marrow metastasis.

Authors:  Tal Teitz; Madoka Inoue; Marcus B Valentine; Kejin Zhu; Jerold E Rehg; Wei Zhao; David Finkelstein; Yong-Dong Wang; Melissa D Johnson; Christopher Calabrese; Marcelo Rubinstein; Razqallah Hakem; William A Weiss; Jill M Lahti
Journal:  Cancer Res       Date:  2013-03-27       Impact factor: 12.701

Review 10.  Caspase-8 as a regulator of tumor cell motility.

Authors:  R P Graf; N Keller; S Barbero; D Stupack
Journal:  Curr Mol Med       Date:  2014-02       Impact factor: 2.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.